Oncolytics Biotech Inc ONCY

Primary Symbol: T.ONC

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Bracelet

<< Previous

Bullboard Posts

Next >>

Comment by Azzak34on Jun 21, 2024 8:53am

41 Views

Post# 36099598

RE:RE:RE:RE:RE:RE:RE:RE:RE:Bracelet

Buck posted a stupid comment and your rebuttal was unnecessary as we've all had this conversation before. You are passive aggressive serial poster on multiple sites.

You have absolutely no idea what's going other than the stock price. Your daily barrage of conjecture and utter nonsense are a waste of time. You have contributed zero to enhance anyone's understanding of ONCY, Pela or the industry in general.

Again, you are not in the know, nor are you "de man".

<< Previous

Bullboard Posts

Next >>

High Tide adds two stores to undervalued cannabis retail network